Literature DB >> 17092759

Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells.

Meng-Hsun Wu1, James Yi-Hsin Chan, Pei-Yao Liu, Shu-Ting Liu, Shih-Ming Huang.   

Abstract

Steroid hormones are proposed to act with human papillomaviruses (HPVs) as cofactors in the etiology of cervical cancer. Steroid hormone-activated nuclear receptors (NRs) are thought to bind to specific DNA sequences within transcriptional regulatory regions on the HPV DNA to either increase or suppress transcription of dependent genes. HPV-induced immortalization of epithelial cells usually requires integration of the viral DNA into the host cell genome. The integration event causes disruption of the E2 gene: the E2 protein is a transcription factor that regulates expression of the E6 and E7 oncoproteins by binding to four sites within the viral long control region (LCR). Our previous study suggested that E6 and E7 oncoproteins both directly bind to some NRs and serve as their cofactors. Here, we provide several lines of evidence demonstrating that the E2 protein is an NR coactivator through its physical interaction with NRs. In our study, the NR coactivator function of HPV E2 protein in human cervical carcinoma cells was independent of the type of E2, HPV transformation and the p53 status. Our observations also provide evidence suggesting regulatory mechanisms for the LCR involving interaction between the E2 protein and NRs in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092759     DOI: 10.1016/j.biocel.2006.09.008

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  9 in total

1.  Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.

Authors:  Michael R Evans; Claire D James; Molly L Bristol; Tara J Nulton; Xu Wang; Namsimar Kaur; Elizabeth A White; Brad Windle; Iain M Morgan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 2.  Estrogen and ERalpha: culprits in cervical cancer?

Authors:  Sang-Hyuk Chung; Silvia Franceschi; Paul F Lambert
Journal:  Trends Endocrinol Metab       Date:  2010-04-22       Impact factor: 12.015

Review 3.  Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma.

Authors:  Daniel L Miller; Michael D Puricelli; M Sharon Stack
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

4.  NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein.

Authors:  Szu-Wei Chang; Yeou-Ping Tsao; Chia-Yi Lin; Show-Li Chen
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

5.  Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes.

Authors:  Szu-Wei Chang; Wei-Chen Liu; Kuan-Yu Liao; Yeou-Ping Tsao; Pang-Hung Hsu; Show-Li Chen
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

6.  Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.

Authors:  Christian T Fontan; Dipon Das; Molly L Bristol; Claire D James; Xu Wang; Hannah Lohner; Azeddine Atfi; Iain M Morgan
Journal:  mSphere       Date:  2020-12-09       Impact factor: 4.389

7.  Sequence variation analysis of HPV-18 isolates in southwest China.

Authors:  Mengjie Shen; Xianping Ding; Tianjun Li; Gangyi Chen; Xiao Zhou
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

8.  Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics.

Authors:  Ignacio E Sánchez; Mariano Dellarole; Kevin Gaston; Gonzalo de Prat Gay
Journal:  Nucleic Acids Res       Date:  2007-12-15       Impact factor: 16.971

9.  Opposing Effects of Zac1 and Curcumin on AP-1-Regulated Expressions of S100A7.

Authors:  Yu-Wen Chu; Shu-Ting Liu; Hsiao-Chun Cheng; Shih-Ming Huang; Yung-Lung Chang; Chien-Ping Chiang; Ying-Chun Liu; Wei-Ming Wang
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.